Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by gait and postural disturbance, gaze palsy, apathy, decreased verbal fluency and dysexecutive symptoms, with some of these clinical features potentially having origins in degeneration of frontostriatal circuits and the mesencephalon. This hypothesis was investigated by manual segmentation of the caudate and putamen on MRI scans, using previously published protocols, in 15 subjects with PSP and 15 healthy age-matched controls. Midbrain atrophy was assessed by measurement of mid-sagittal area of the midbrain and pons. Shape analysis of the caudate and putamen was performed using spherical harmonics (SPHARM-PDM, University of North Carolina). The sagittal pons area/midbrain area ratio (P/M ratio) was significantly higher in the PSP group, consistent with previous findings. Significantly smaller striatal volumes were found in the PSP groupputamina were 10% smaller and caudate volumes were 17% smaller than in controls after controlling for age and intracranial volume. Shape analysis revealed significant shape deflation in PSP in the striatum, compared to controls; with regionally significant change relevant to frontostriatal and corticostriatal circuits in the caudate. Thus, in a clinically diagnosed and biomarker-confirmed cohort with early PSP, we demonstrate that neostriatal volume and shape are significantly reduced in vivo. The findings suggest a neostriatal and mesencephalic structural basis for the clinical features of PSP leading to frontostriatal and mesocorticalstriatal circuit disruption.
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Introduction
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by postural instability and gait disturbance, bradykinesia and axial rigidity, vertical gaze palsy and bulbar palsy (Steele et al., 1964) , in combination with neuropsychiatric symptoms such as apathy and utilization behavior. Cognitive and behavioral features in PSP involve functional domains ascribed neuroanatomically to the fronto-striato-pallido-thalamic-cortical (frontostriatal) reentrant circuits (Alexander et al., 1986; Cummings, 1993) . PSP has a progressive and irreversible course, with disease duration usually between 6 and 12 years (Williams and Lees, 2009).
The molecular pathology of PSP is characterized by accumulation of tau protein and neuropil filaments within the pallidum, subthalamic nucleus, red nucleus, oculomotor nucleus, dentate nucleus, medulla, ventral tegmentum and neostriatum (caudate and especially putamen) (Williams and Lees, 2009) . Macroscopic atrophy of the frontal cortex (Cordato et al., 2002) and subcortical structures (Schulz et al., 1999; Schrag et al., 2000) distinguishes PSP from other parkinsonian syndromes on MRI. Subcortical atrophy in PSP affects the midbrain (particularly the ventral tegmentum), neostriatum, mamillary bodies and the superior cerebellar peduncle (Schrag et al., 2000) , with the neostriatum and midbrain involved in frontostriatal circuits. Hence, there is morphological evidence that frontostriatal pathways may be disrupted by PSP.
Given the strategic location of the neostriatum in frontostriatal circuits, there have been surprisingly few attempts to quantify neostriatal atrophy as a structural basis for the neuropsychiatric Psychiatry Research: Neuroimaging 194 (2011) 163-175 
